Abstract
Although tremendous strides have recently been made in the development of assessment and treatment methods for pediatric obsessive-compulsive disorder (OCD), more accurate methods for diagnosis, more effective treatments, and more refined instruments for monitoring progress during therapy are still needed. The present commentary highlights the papers in this series of articles. The excellent work by the contributors to this special edition highlights critical elements and limitations of the assessment process for OCD, the importance of monitoring symptom changes, and possible augmentation strategies for treatment refractory cases. The findings from these studies will almost certainly impact the management of pediatric OCD and lead to further refinements.
Similar content being viewed by others
References
Abramowitz, J. S., Franklin, M. E., Zoellner, L. A., & DiBernardo, C. L. (2002). Treatment compliance and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. Behavior Modification, 26, 447–463.
Abramowitz, J. S., Taylor, S., & McKay, D. (2009). Obsessive-compulsive disorder. The Lancet, 374, 491–499.
Freeman, J., Garcia, A., Coyne, L., Ale, C., Przeworksi, A., Himle, M., et al. (2008). Early childhood OCD: Preliminary findings from a family-based cognitive-behavioral approach. Journal of American Academy of Child and Adolescent Psychiatry, 47(5), 593–602.
Ivarsson, T., Thomsen, P. H., Dahl, K., Valderhaug, R., Weidle, B., Nissen, J. B., et al. (2010). The rationale and some features of the Nordic Long-term OCD treatment study (NordLOTS) in childhood and adolescence. Child and Youth Care Forum. doi:10.1007/s10566-010-9097-3.
Lewin, A., & Piacentini, J. (2010). Evidence-based assessment of child obsessive compulsive disorder: Recommendations for clinical practice and treatment research. Child and Youth Care Forum. doi:10.1007/s10566-009-9092-8.
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008). A meta-analysis of d-Cycloserine and the facilitation of extinction and exposure therapy for learned fear. Biological Psychiatry, 63, 1118–1126.
POTS. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The pediatric OCD treatment study (POTS) randomized controlled trial. Journal of the American Medical Association, 292, 1969–1976.
Reid, J. M., Storch, E. A., Murphy, T. K., Bodzin, D., Mutch, J., Lehmkuhl, H., et al. (2010). Development and psychometric evaluation of the treatment-emergent activation and suicidality assessment profile. Child and Youth Care Forum. doi:10.1007/s10566-010-9095-5.
Storch, C., McKay, D., Reid, J., Geller, D., Goodman, W., & Murphy, T. (2010). d-Cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder: Rationale, design, and methods. Child and Youth Care Forum. doi:10.1007/s10566-010-9094-6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berman, N.C., Abramowitz, J.S. Recent Developments in the Assessment and Treatment of Pediatric Obsessive-Compulsive Disorder. Child Youth Care Forum 39, 125–127 (2010). https://doi.org/10.1007/s10566-010-9096-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10566-010-9096-4